Medical Devices Startups

Augustine Therapeutics is a biotech company developing HDAC6-targeted therapies for peripheral neuropathies such as Charcot-Marie-Tooth disease and chemotherapy-induced peripheral neuropathy, as well as neurodegenerative disorders like ALS. Founded as a spin-off from VIB and KU Leuven, it focuses on drug development for currently untreatable complex neurological diseases.

5 investors

Autobahn Therapeutics develops orally administered small molecule prodrugs using a brain-targeting chemistry platform to create regenerative medicines for central nervous system (CNS) disorders. The company targets both rare and prevalent brain diseases, using biomarker-driven development strategies to demonstrate on-target activity early in clinical trials.

5 investors

Avasa develops technology to simplify microsurgical procedures, replacing manual hand sewing with automated microvascular connection methods.

5 investors

5 investors

Avidity Biosciences develops Antibody Oligonucleotide Conjugates (AOCs) that combine monoclonal antibody specificity with oligonucleotide precision for targeted delivery of RNA therapeutics to treat rare genetic muscle diseases. The company has three clinical-stage programs targeting myotonic dystrophy type 1, facioscapulohumeral muscular dystrophy, and Duchenne muscular dystrophy.

5 investors

Babylon is a digital health company that develops prescription medications and treatments for specific health conditions. The company's portfolio includes Xiidra, an FDA-approved eye drop for treating dry eye disease in adults.

5 investors

Baebies develops multifunctional syndromic diagnostic testing using proprietary digital microfluidics, integrating molecular, immunoassay, chemistry, and coagulation testing into a single compact platform (FINDER) that runs on small-volume samples. Its products serve hospitals, clinics, pharmacies, and decentralized care settings for patients of all ages, having started with newborn and pediatric diagnostics.

5 investors

Better Health provides home-based support for people living with chronic conditions, offering trained peer coaching, medical supply delivery with insurance handling, and patient education. It works with Medicare and other insurance plans and serves individuals, insurance payers, and healthcare providers.

5 investors

BioProtect develops a balloon spacer used in radiation therapy to create uniform anterior-posterior spacing and reduce radiation dose to surrounding tissue during treatments such as prostate cancer radiotherapy. Positioned as the first non-gel spacer for modern radiation therapies, it targets physicians and patients undergoing hypofractionated and SBRT treatments.

5 investors

BioAesthetics develops NACgraft, a cell-free, collagen-rich nipple-areolar complex graft that a surgeon applies so the patient's own cells integrate it into living nipple and areola tissue. It targets breast cancer survivors who have undergone mastectomies and lost their nipples, operating in the biomaterials and medical device field.

5 investors

BIOS develops neural digital therapy technology to deliver treatments for neurological conditions. The company combines neural engineering with AI and machine learning to improve healthcare outcomes and restore patient control over bodily function.

5 investors

Brixton Bio develops Reneurx therapy, a treatment aimed at providing long-lasting pain relief for up to six months from a single administration. The company operates in the biotech and therapeutics space focused on pain control.

5 investors

Cadence develops a neuromodulation system intended to be a more effective, less invasive treatment for people living with drug-refractory epilepsy. The medical device is designed to be adaptable to individual patient needs and was developed in collaboration with Mayo Clinic.

5 investors

Carrick Therapeutics is a biopharmaceutical company with a leadership team experienced in oncology drug development and commercialization. The company focuses on developing and advancing cancer treatments through clinical development and business development activities.

5 investors

Cellares develops automated manufacturing systems and technology platforms to accelerate the production and commercialization of cell therapies. The company serves biopharmaceutical manufacturers and cell therapy developers worldwide.

5 investors

Cellular Intelligence develops cell therapy treatments, specifically acquiring STEM-PD, a Phase 2-ready therapy for Parkinson's disease. The company focuses on cell fate engineering to design biological solutions for neurological diseases.

5 investors

Checkpoint Surgical develops intraoperative nerve stimulation devices, biomaterial implants, and surgical instruments for peripheral nerve and tendon surgery. The company produces ACMShield, a dehydrated placental membrane allograft used as a protective barrier in surgical applications.

5 investors

ChromaCode develops a High-Definition PCR (HDPCR) multiplexing platform that enables genomic solutions for oncology and precision medicine, offering faster results and cost-effective workflows through automated interpretation and cloud-based software.

5 investors

Citruslabs is a clinical research organization that designs and runs consumer perception studies, clinical trials, and randomized controlled trials for health and wellness brands including supplements, skincare, pet health, biotech, and functional foods. The company translates study results into marketing-ready, regulator-reviewed product claims for consumer health brands that traditionally lack access to affordable clinical evidence.

5 investors

CMR Surgical develops Versius, a small, modular, and portable surgical robot that enables hospitals and surgeons to perform minimal access (keyhole) surgery. The company also provides a digital ecosystem offering data and insights to support surgical teams across specialties including thoracic, general, gynaecology, and colorectal surgery.

5 investors

Coherence develops neurotechnology systems that measure and modulate brain activity to treat cancer and other neurological diseases. The company uses bioelectronic interfaces and AI to decode the body's neural signals and enable precise, adaptive therapeutic interventions.

5 investors

CorInnova develops a minimally invasive, non-blood contacting cardiac assist device designed to treat acute heart failure patients who cannot use existing solutions. The collapsible device is delivered via minimally invasive procedures and compresses the heart externally to increase cardiac output without the risks of blood clotting, stroke, or anticoagulation-related complications.

5 investors

DeepLook Medical develops DL Precise, an FDA-cleared medical imaging software that offers one-click segmentation and tumor morphology display across multiple modalities. It serves radiologists and healthcare providers, focusing on breast cancer detection and diagnostic imaging, including for patients with dense breast tissue.

5 investors

Doccla provides a remote patient monitoring service that connects medical devices and EHR systems to keep patients monitored at home, combining device logistics, project management and a CQC-registered clinical team of nurses, GPs and paramedics. It serves healthcare providers such as NHS trusts and hospitals to extend virtual care capacity and reduce the cost of care.

5 investors